Publikationen in Zusammenarbeit mit Forschern von Hospital del Mar (6)

2024

  1. First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN

    Breast Cancer Research and Treatment

2020

  1. Clinical significance of a microRNA signature for the identification and predicting prognosis in colorectal cancers with mucinous differentiation

    Carcinogenesis, Vol. 41, Núm. 11, pp. 1498-1506

2013

  1. Adjuvant therapy with cetuximab for locally advanced squamous cell carcinoma of the oropharynx: Results from a randomized, phase II prospective trial

    Annals of Oncology, Vol. 24, Núm. 2, pp. 448-453

2011

  1. Molecular markers of endometrial carcinoma detected in uterine aspirates

    International Journal of Cancer, Vol. 129, Núm. 10, pp. 2435-2444

2010

  1. Activity of a multitargeted chemo-switch regimen (sorafenib, gemcitabine, and metronomic capecitabine) in metastatic renal-cell carcinoma: A phase 2 study (SOGUG-02-06)

    The Lancet Oncology, Vol. 11, Núm. 4, pp. 350-357

2009

  1. Proteomic approach to ETV5 during endometrial carcinoma invasion reveals a link to oxidative stress

    Carcinogenesis, Vol. 30, Núm. 8, pp. 1288-1297